Allen Institute for Artificial Intelligence
supp.ai logo
supp.ai

Discover Supplement-Drug Interactions

Disclaimer: The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The tool is not a substitute for the care provided… (more)
Last Updated: 5 years ago

Possible Interaction: Galantamine and Niacin

supplement:

Niacin

Research Papers that Mention the Interaction

“These studies suggest that not only the nicotinic receptor-modulating properties but also the muscarinic receptor activation contribute to the antipsychotic effect and improvement of cognitive dysfunction by galantamine.”
Journal of pharmacological sciences  •  2011  |  View Paper
“In conclusion, the nicotinic APL action can be an important determinant of the therapeutic effectiveness of galantamine.”
Molecular pharmacology  •  2002  |  View Paper
“ Galantamine is also a selective booster of nicotinic action by allosterically modulating nicotinic receptors.”
The Journal of clinical psychiatry  •  2000  |  View Paper
“It was previously shown that the nootropic drugs nefiracetam and galantamine potentiate the activity of both nicotinic and NMDA receptors.”
Journal of Pharmacology and Experimental Therapeutics  •  2005  |  View Paper
“ Galantamine is a compound that possesses two interesting properties: inhibition of acetylcholinesterase and positive allosteric modulation of nicotinic neurotransmission.”
Life sciences  •  2003  |  View Paper
“Exogenous ligands such as galanthamine and the neurotransmitter 5-hydroxytryptamine, when applied in submicromolar concentrations with nicotinic agonists, significantly increase the frequency of opening of nicotinic receptor channels and potentiate agonist-activated currents.”
Molecular pharmacology  •  1996  |  View Paper
“In addition to inhibiting the breakdown of acetylcholine, galantamine augments the sensitivity to nicotinic agonists by modeling the structure of the nicotinic receptor.”
Acta Neuropsychiatrica  •  2004  |  View Paper